Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jessica E Hutti

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Plos One|August 4, 2012
Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKεJessica E Hutti, Melissa A Porter, Adam W Cheely, et al.
Nature Methods|March 23, 2005
A rapid method for determining protein kinase phosphorylation specificityJessica E Hutti, Emily T Jarrell, James D Chang, et al.
The Biochemical Journal|September 11, 2009
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's diseaseR Jeremy Nichols, Nicolas Dzamko, Jessica E Hutti, et al.
Leukemia & Lymphoma|December 13, 2025
Treatment patterns and overall survival among patients with myelodysplastic syndromes treated in the US community oncology setting: a real-world retrospective observational studyRoger Lyons, Yanqing Xu, Cherrishe Brown-Bickerstaff, et al.
Molecular Cell|June 2, 2009
Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformationJessica E Hutti, Rhine R Shen, Derek W Abbott, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
Building a human kinase gene repository: bioinformatics, molecular cloning, and functional validationJaehong Park, Yanhui Hu, T V S Murthy, et al.
The CRISPR Journal|August 23, 2019
<i>VHL</i> Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 ScreensNing Sun, Sakina Petiwala, Charles Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid TumorsSarina A Piha-Paul, Jasgit C Sachdev, Minal Barve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2022
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and EfficacyClaire N Harrison, Jacqueline S Garcia, Tim C P Somervaille, et al.
Journal of Medicinal Chemistry|July 14, 2018
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315Clarissa G Jakob, Anup K Upadhyay, Pamela L Donner, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Plos One|August 4, 2012
Development of a high-throughput assay for identifying inhibitors of TBK1 and IKKεJessica E Hutti, Melissa A Porter, Adam W Cheely, et al.
Nature Methods|March 23, 2005
A rapid method for determining protein kinase phosphorylation specificityJessica E Hutti, Emily T Jarrell, James D Chang, et al.
The Biochemical Journal|September 11, 2009
Substrate specificity and inhibitors of LRRK2, a protein kinase mutated in Parkinson's diseaseR Jeremy Nichols, Nicolas Dzamko, Jessica E Hutti, et al.
Leukemia & Lymphoma|December 13, 2025
Treatment patterns and overall survival among patients with myelodysplastic syndromes treated in the US community oncology setting: a real-world retrospective observational studyRoger Lyons, Yanqing Xu, Cherrishe Brown-Bickerstaff, et al.
Molecular Cell|June 2, 2009
Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformationJessica E Hutti, Rhine R Shen, Derek W Abbott, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 2, 2005
Building a human kinase gene repository: bioinformatics, molecular cloning, and functional validationJaehong Park, Yanhui Hu, T V S Murthy, et al.
The CRISPR Journal|August 23, 2019
<i>VHL</i> Synthetic Lethality Signatures Uncovered by Genotype-Specific CRISPR-Cas9 ScreensNing Sun, Sakina Petiwala, Charles Lu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 18, 2019
First-in-Human Study of Mivebresib (ABBV-075), an Oral Pan-Inhibitor of Bromodomain and Extra Terminal Proteins, in Patients with Relapsed/Refractory Solid TumorsSarina A Piha-Paul, Jasgit C Sachdev, Minal Barve, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 18, 2022
Addition of Navitoclax to Ongoing Ruxolitinib Therapy for Patients With Myelofibrosis With Progression or Suboptimal Response: Phase II Safety and EfficacyClaire N Harrison, Jacqueline S Garcia, Tim C P Somervaille, et al.
Journal of Medicinal Chemistry|July 14, 2018
Novel Modes of Inhibition of Wild-Type Isocitrate Dehydrogenase 1 (IDH1): Direct Covalent Modification of His315Clarissa G Jakob, Anup K Upadhyay, Pamela L Donner, et al.
Pageof 2